Hemant Kumar Vyas

Hemant Kumar Vyas

Hemant Kumar Vyas
Texas Biomedical Research Institute, Virology and Immunology, 7620 NW loop 410, San Antonio, Texas 78227
USA

Biography

Dr. Vyas is currently a postdoctoral research scientist V at Texas Biomedical Research Institute San Antonio, Texas. He worked as a postdoctoral associate at Harvard Medical School and a research fellow with Prof. Ruth Ruprecht in the Department of Cancer Immunology and AIDS at Dana-Farber Cancer Institute, Boston. Dr. Vyas received his Ph.D. in Life Sciences from the University of Rajasthan, Jaipur in 2010. He received his masters’ degree in Biotechnology from Rajasthan Agricultural University, Bikaner, in 2003 and graduation B.Sc. (Ag.) honors in 2001. His current research interest lies in the development of an AIDS vaccine that will induce protective antibodies to HIV. He is investigating vaccine based humoral responses in primates, and designing and engineering epitope based antibodies and assaying their effectiveness for HIV-vaccine development. Dr Vyas’s postgraduate research experience spans diverse fields including transgenic plant science for antibody production, single chain variable fragment designing, bio-organic chemistry, cancer cell biology and engineering of designer antibodies and immunoconjugates for immunotherapy of advance stage cancers. He joined Prof G.P.Talwar’s research group in 2003 and worked in collaborative projects under Dr. Rahul Pal and Dr. R. Vishwakarma at National Institute of Immunology. He has contributed to the field of biomedical molecular engineering by developing non-toxic immunoconjugate which selectively targets advanced stage cancer cells. His achievements in research have been recognized at international meetings and published in peer reviewed journals. His doctoral research on development of antibody for therapeutic and effector functions has laid the foundation of his work leading to studies on selective memory B cells, generating antibodies from single B cells for prevention, treatment and diagnosis of infectious diseases.

Research Interest

HIV-vaccine, Cancer